Runnymede Capital Advisors, Inc. Navidea Biopharmaceuticals, Inc. Transaction History

Runnymede Capital Advisors, Inc.

  • $114 Billion
  • Q4 2024

A detailed history of Runnymede Capital Advisors, Inc. transactions in Navidea Biopharmaceuticals, Inc. stock. As of the latest transaction made, Runnymede Capital Advisors, Inc. holds 5 shares of NAVB stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Holding current value
$0
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$0.0 - $0.0 $0 - $0
5 New
5 $0

Others Institutions Holding NAVB

# of Institutions
2
Shares Held
10K
Call Options Held
0
Put Options Held
0
View Full List

About NAVIDEA BIOPHARMACEUTICALS, INC.

NAVB Quotes by TradingView
  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Runnymede Capital Advisors, Inc. Portfolio

Follow Runnymede Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Runnymede Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Runnymede Capital Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email